J M Kaminski

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. ncbi request reprint Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools
    Craig J Coates
    Department of Entomology, Texas A and M University, College Station, TX 77843, USA
    Trends Biotechnol 23:407-19. 2005
  2. ncbi request reprint Defining a future role for radiogenic therapy
    J M Kaminski
    Department of Radiology, Medical College of Georgia, Augusta 30912, USA
    Cancer Treat Rev 27:289-94. 2001
  3. ncbi request reprint Prostate cancer gene therapy and the role of radiation
    J M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burolme Avenue, Philadelphia, PA 19111, USA
    Cancer Treat Rev 28:49-64. 2002
  4. ncbi request reprint Design of a nonviral vector for site-selective, efficient integration into the human genome
    Joseph M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    FASEB J 16:1242-7. 2002
  5. ncbi request reprint Intracranial fibrosarcoma arising 5 years after chemotherapy alone for glioblastoma multiforme in a child
    J M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, Albert Einstein Medical Center, Philadelphia, PA, USA
    Pediatr Neurosurg 33:257-260. 2000
  6. ncbi request reprint Metastatic meningioma to the lung with multiple pleural metastases
    J M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Am J Clin Oncol 24:579-82. 2001
  7. ncbi request reprint Active integration: new strategies for transgenesis
    Eric T Shinohara
    Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Transgenic Res 16:333-9. 2007
  8. pmc piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells
    Sareina Chiung Yuan Wu
    Cancer Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Proc Natl Acad Sci U S A 103:15008-13. 2006
  9. ncbi request reprint Immunotherapy and prostate cancer
    Joseph M Kaminski
    Department of Radiology, Medical College of Georgia, Augusta, GA 30912, USA
    Cancer Treat Rev 29:199-209. 2003
  10. ncbi request reprint Site-directed genome modification: nucleic acid and protein modules for targeted integration and gene correction
    Andreas F Kolb
    Hannah Research Institute, Hannah Research Park, Ayr, UK, KA6 5HL
    Trends Biotechnol 23:399-406. 2005

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools
    Craig J Coates
    Department of Entomology, Texas A and M University, College Station, TX 77843, USA
    Trends Biotechnol 23:407-19. 2005
    ..In addition, we discuss the approaches that have been taken to improve the efficiency and to modify the site-specificity of these enzymes...
  2. ncbi request reprint Defining a future role for radiogenic therapy
    J M Kaminski
    Department of Radiology, Medical College of Georgia, Augusta 30912, USA
    Cancer Treat Rev 27:289-94. 2001
    ..g. radiolabelled substance). We have termed this group of therapeutics radiogenic therapy...
  3. ncbi request reprint Prostate cancer gene therapy and the role of radiation
    J M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burolme Avenue, Philadelphia, PA 19111, USA
    Cancer Treat Rev 28:49-64. 2002
    ..With further technological advances in radiation therapy, gene therapy, and the understanding of prostate cancer biology, gene therapy will potentially have an important role in prostate cancer therapy...
  4. ncbi request reprint Design of a nonviral vector for site-selective, efficient integration into the human genome
    Joseph M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    FASEB J 16:1242-7. 2002
    ....
  5. ncbi request reprint Intracranial fibrosarcoma arising 5 years after chemotherapy alone for glioblastoma multiforme in a child
    J M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, Albert Einstein Medical Center, Philadelphia, PA, USA
    Pediatr Neurosurg 33:257-260. 2000
    ..She remains alive and recurrence-free 7 years following the diagnosis of her second intracranial malignancy...
  6. ncbi request reprint Metastatic meningioma to the lung with multiple pleural metastases
    J M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Am J Clin Oncol 24:579-82. 2001
    ..We report an interesting case of a malignant meningioma that invaded through the skull in the frontal sinus that later metastasized to the left lung with multiple pulmonary and pleural nodules...
  7. ncbi request reprint Active integration: new strategies for transgenesis
    Eric T Shinohara
    Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Transgenic Res 16:333-9. 2007
    ..Subsequently, these methods may someday be used for gene therapy in humans...
  8. pmc piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells
    Sareina Chiung Yuan Wu
    Cancer Research Center, Medical College of Georgia, Augusta, GA 30912, USA
    Proc Natl Acad Sci U S A 103:15008-13. 2006
    ..The high transposition activity of piggyBac and the flexibility for molecular modification of its transposase suggest the possibility of using it routinely for mammalian transgenesis...
  9. ncbi request reprint Immunotherapy and prostate cancer
    Joseph M Kaminski
    Department of Radiology, Medical College of Georgia, Augusta, GA 30912, USA
    Cancer Treat Rev 29:199-209. 2003
    ..Many obstacles exist in immunotherapy, including vector design, tumouricidal specificity, and tumor evasion, which will have to be overcome in order to realize the maximum therapeutic benefit from this treatment modality...
  10. ncbi request reprint Site-directed genome modification: nucleic acid and protein modules for targeted integration and gene correction
    Andreas F Kolb
    Hannah Research Institute, Hannah Research Park, Ayr, UK, KA6 5HL
    Trends Biotechnol 23:399-406. 2005
    ..This review will describe recent progress in the development of 'user-targetable' systems, particularly highlighting the application of custom DNA-binding proteins or nucleic acid homology to confer specificity...
  11. ncbi request reprint Functional zinc finger/sleeping beauty transposase chimeras exhibit attenuated overproduction inhibition
    Matthew H Wilson
    Department of Medicine, Division of Genetic Medicine, 529 Light Hall, Vanderbilt University, Nashville, TN 37232 0275, USA
    FEBS Lett 579:6205-9. 2005
    ..These findings suggest that SB transposase chimeras may have specific advantages over the native enzyme...
  12. ncbi request reprint Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control
    Joseph M Kaminski
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 52:888-92. 2002
    ..Two subgroups were studied: favorable (PSA <10 ng/mL, Gleason score 2-6, and T1-T2A) and unfavorable (one or more: PSA >/=10 ng/mL, Gleason score 7-10, T2B-T3)...
  13. doi request reprint Steps toward targeted insertional mutagenesis with class II transposable elements
    Sareina Chiung Yuan Wu
    Department of Entomology, Texas A and M University, College Station, TX
    Methods Mol Biol 435:139-51. 2008
    ..Herein, we provide a brief background on targeted transposon integration and detailed protocols for testing chimeric transposases in both mammalian cell culture and insect embryos...